|
1
|
De Lecea L, Kilduff TS, Peyron C, et al:
The hypocretins: hypothalamus-specific peptides with
neuroexcitatory activity. Proc Natl Acad Sci USA. 95:322–327. 1998.
View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Sakurai T, Amemiya A, Ishii M, et al:
Orexins and orexin receptors: a family of hypothalamic
neuropeptides and G protein-coupled receptors that regulate feeding
behavior. Cell. 92:573–585. 1998. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Karteris E and Randeva HS: Orexin
receptors and G-protein coupling: evidence for another
‘promiscuous’ seven transmembrane domain receptor. J Pharmacol Sci.
93:126–128. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Nakabayashi M, Suzuki T, Takahashi K, et
al: Orexin-A expression in human peripheral tissues. Mol Cell
Endocrinol. 205:43–50. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Korczynski W, Ceregrzyn M, Matyjek R, et
al: Central and local (enteric) action of orexins. J Physiol
Pharmacol. 57:17–42. 2006.
|
|
6
|
Okumura T and Nozu T: Role of brain orexin
in the pathophysiology of functional gastrointestinal disorders. J
Gastroenterol Hepatol. 26:61–66. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Kagerer S, M and Jöhren O: Interactions of
orexins/hypocretins with adrenocortical functions. Acta Physiol.
198:361–371. 2010. View Article : Google Scholar
|
|
8
|
Jöhren O, Neidert S, J, Kummer M, et al:
Prepro-orexin and orexin receptor mRNAs are differentially
expressed in peripheral tissues of male and female rats.
Endocrinology. 142:3324–3331. 2001. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Xu TR, Yang Y, Ward R, Gao L and Liu Y:
Orexin receptors: multi-functional therapeutic targets for sleeping
disorders, eating disorders, drug addiction, cancers and other
physiological disorders. Cell Signal. 25:2413–2423. 2013.
View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Heinonen MV, Purhonen AK, Makela KA and
Herzig KH: Functions of orexins in peripheral tissues. Acta
Physiologica. 192:471–485. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Rouet-Benzineb P, Rouyer-Fessard C, Jarry
A, et al: Orexins acting at native OX1 receptor in colon cancer and
neuroblastoma cells or at recombinant OX1 receptor suppress cell
growth by inducing apoptosis. J Biol Chem. 279:45875–45886. 2004.
View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Voisin T, El Firar A, Fasseu M, et al:
Aberrant expression of OX1 receptors for orexins in colon cancers
and liver metastases: an openable gate to apoptosis. Cancer Res.
71:3341–3351. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Voisin T, El Firar A, Avondo V, et al:
Orexin-induced apoptosis: the key role of the seven-transmembrane
domain orexin type 2 receptor. Endocrinology. 147:4977–4984. 2006.
View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Bieganska K, Sokolowska P, Johren O and
Zawilska JB: Orexin A suppresses the growth of rat C6 glioma cells
via a caspase-dependent mechanism. J Mol Neurosci. 48:706–712.
2012. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Ammoun S, Lindholm D, Wootz H, et al:
G-protein-coupled OX1 orexin/hcrtr-1 hypocretin receptors induce
caspase-dependent and-independent cell death through p38
mitogen-/stress-activated protein kinase. J Biol Chem. 281:834–842.
2006. View Article : Google Scholar
|
|
16
|
Roberts PJ and Der CJ: Targeting the
Raf-MEK-ERK mitogen-activated protein kinase cascade for the
treatment of cancer. Oncogene. 26:3291–3310. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Hong SK, Yoon S, Moelling C, et al:
Noncatalytic function of ERK1/2 can promote Raf/MEK/ERK-mediated
growth arrest signaling. J Biol Chem. 284:33006–33018. 2009.
View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Tian PY and Fan XM: The proliferative
effects of ghrelin on human gastric cancer AGS cells. J Dig Dis.
13:453–458. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Qian C, Yao J, Wang J, et al: ERK1/2
inhibition enhances apoptosis induced by JAK2 silencing in human
gastric cancer SGC7901 cells. Mol Cell Biochem. 387:159–170. 2014.
View Article : Google Scholar
|
|
20
|
Wu S, Lao XY, Sun TT, et al: Knockdown of
ZFX inhibits gastric cancer cell growth in vitro and in vivo via
down-regulating the ERK-MAPK pathway. Cancer Lett. 337:293–300.
2013. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Dehan P, Canon C, Trooskens G, et al:
Expression of type 2 orexin receptor in human endometrium and its
epigenetic silencing in endometrial cancer. J Clin Endocr Metab.
98:1549–1557. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Malendowicz W, Szyszka M, Ziolkowska A, et
al: Elevated expression of orexin receptor 2 (HCRTR2) in benign
prostatic hyperplasia is accompanied by lowered serum orexin A
concentrations. Int J Mol Med. 27:377–383. 2011. View Article : Google Scholar
|
|
23
|
Spinazzi R, Rucinski M, Neri G, et al:
Preproorexin and orexin receptors are expressed in
cortisol-secreting adrenocortical adenomas, and orexins stimulate
in vitro cortisol secretion and growth of tumor cells. J Clin
Endocr Metab. 90:3544–3549. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Spinazzi R, Ziolkowska A, Neri G, et al:
Orexins modulate the growth of cultured rat adrenocortical cells,
acting through type 1 and type 2 receptors coupled to the MAPK
p42/p44-and p38-dependent cascades. Int J Mol Med. 15:847–852.
2005.PubMed/NCBI
|
|
25
|
Raman M, Chen W and Cobb MH: Differential
regulation and properties of MAPKs. Oncogene. 26:3100–3112. 2007.
View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Ballif BA and Blenis J: Molecular
mechanisms mediating mammalian mitogen-activated protein kinase
(MAPK) kinase (MEK)-MAPK cell survival signals. Cell Growth Differ.
12:397–408. 2001.PubMed/NCBI
|
|
27
|
Junttila MR, Li S-P and Westermarck J:
Phosphatase-mediated crosstalk between MAPK signaling pathways in
the regulation of cell survival. FASEB J. 22:954–965. 2008.
View Article : Google Scholar
|
|
28
|
Yan L, Gu H, Li J, et al: RKIP and 14-3-3ε
exert an opposite effect on human gastric cancer cells SGC7901 by
regulating the ERK/MAPK pathway differently. Dig Dis Sci.
58:389–396. 2013. View Article : Google Scholar
|
|
29
|
Santarpia L, Lippman SM and El-Naggar AK:
Targeting the MAPK-RAS-RAF signaling pathway in cancer therapy.
Expert Opin Ther Targets. 16:103–119. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Fang JY and Richardson BC: The MAPK
signaling pathways and colorectal cancer. Lancet Oncol. 6:322–327.
2005. View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Kadowaki Y, Ishihara S, Miyaoka Y, et al:
Reg protein is overexpressed in gastric cancer cells, where it
activates a signal transduction pathway that converges on ERK1/2 to
stimulate growth. FEBS Lett. 530:59–64. 2002. View Article : Google Scholar : PubMed/NCBI
|
|
32
|
Kim MK, Park HJ, Kim SR, et al: Angiogenic
role of orexin-A via the activation of extracellular
signal-regulated kinase in endothelial cells. Biochem Biophys Res
Commun. 403:59–65. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
33
|
Ramanjaneya M, Conner AC, Chen J, et al:
Orexin-stimulated MAP kinase cascades are activated through
multiple G-protein signaling pathways in human H295R adrenocortical
cells: diverse roles for orexins A and B. J Endocrinol.
202:249–261. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
34
|
Gorojankina T, Grébert D, Salesse R, et
al: Study of orexins signal transduction pathways in rat olfactory
mucosa and in olfactory sensory neurons-derived cell line Odora:
multiple orexin signaling pathways. Regul Pept. 141:73–85. 2007.
View Article : Google Scholar : PubMed/NCBI
|
|
35
|
Skrzypski M, Kaczmarek P, Le TT, et al:
Effects of orexin A on proliferation, survival, apoptosis and
differentiation of 3T3-L1 preadipocytes into mature adipocytes.
FEBS Lett. 586:4157–4164. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
36
|
Igney FH and Krammer PH: Death and
anti-death: tumour resistance to apoptosis. Nat Rev Cancer.
2:277–288. 2002. View
Article : Google Scholar : PubMed/NCBI
|
|
37
|
Hu W and Kavanagh JJ: Anticancer therapy
targeting the apoptotic pathway. Lancet Oncol. 4:721–729. 2003.
View Article : Google Scholar : PubMed/NCBI
|
|
38
|
Sokołowska P, Urbańska A, Namiecińska M,
et al: Orexins promote survival of rat cortical neurons. Neurosci
Lett. 506:303–306. 2012. View Article : Google Scholar
|
|
39
|
Boucher MJ, Duchesne C, Lainé J, et al:
cAMP protection of pancreatic cancer cells against apoptosis
induced by ERK inhibition. Biochem Biophys Res Commun. 285:207–216.
2001. View Article : Google Scholar : PubMed/NCBI
|
|
40
|
Martin MC, Allan LA, Mancini EJ, et al:
The docking interaction of caspase-9 with ERK2 provides a mechanism
for the selective inhibitory phosphorylation of caspase-9 at
threonine 125. J Biol Chem. 283:3854–3865. 2008. View Article : Google Scholar
|
|
41
|
Allan LA, Morrice N, Brady S, et al:
Inhibition of caspase-9 through phosphorylation at Thr 125 by ERK
MAPK. Nat Cell Biol. 5:647–654. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
42
|
Butterick TA, Nixon JP, Billington CJ, et
al: Orexin A decreases lipid peroxidation and apoptosis in a novel
hypothalamic cell model. Neurosci Lett. 524:30–34. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
43
|
Tang J, Chen J, Ramanjaneya M, et al: The
signaling profile of recombinant human orexin-2 receptor. Cell
Signal. 20:1651–1661. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
44
|
Danial NN and Korsmeyer SJ: Cell death:
critical control points. Cell. 116:205–219. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
45
|
Laburthe M, Voisin T and El Firar A:
Orexins/hypocretins and orexin receptors in apoptosis: a
mini-review. Acta Physiol. 198:393–402. 2010. View Article : Google Scholar
|
